Evaluation of symptomatic patient saliva as a sample type for the Abbott ID NOW COVID-19 assay
Jeffrey A. SoRelle, Lenin Mahimainathan, Clare McCormick-Baw, Dominick Cavuoti, Francesca Lee, Anjali Bararia, Abey Thomas, Ravi Sarode, Andrew E. Clark, Alagarraju Muthukumar
doi: https://doi.org/10.1101/2020.06.01.20119198
Jeffrey A. SoRelle
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
MDLenin Mahimainathan
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
PhD, MB(ASCP)Clare McCormick-Baw
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
MD, PhD, FCAPDominick Cavuoti
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
DOFrancesca Lee
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
MDAnjali Bararia
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
MSc., M(ASCP) CMAbey Thomas
2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
MDRavi Sarode
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
MDAndrew E. Clark
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
PhD, D(ABMM)Alagarraju Muthukumar
1Department of Pathology and Clinical Laboratory Services, University of Texas Southwestern Medical Center, Dallas, Texas
PhD, DABCCArticle usage
Posted June 03, 2020.
Evaluation of symptomatic patient saliva as a sample type for the Abbott ID NOW COVID-19 assay
Jeffrey A. SoRelle, Lenin Mahimainathan, Clare McCormick-Baw, Dominick Cavuoti, Francesca Lee, Anjali Bararia, Abey Thomas, Ravi Sarode, Andrew E. Clark, Alagarraju Muthukumar
medRxiv 2020.06.01.20119198; doi: https://doi.org/10.1101/2020.06.01.20119198
Evaluation of symptomatic patient saliva as a sample type for the Abbott ID NOW COVID-19 assay
Jeffrey A. SoRelle, Lenin Mahimainathan, Clare McCormick-Baw, Dominick Cavuoti, Francesca Lee, Anjali Bararia, Abey Thomas, Ravi Sarode, Andrew E. Clark, Alagarraju Muthukumar
medRxiv 2020.06.01.20119198; doi: https://doi.org/10.1101/2020.06.01.20119198
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)